Skip to main content

Table 3 Data Collection Summary for Sample Characteristics and Eligibility Measures

From: Identifying response and predictive biomarkers for Transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with Pharmacoresistant depression

 

Enrollment

Baseline

1 Week

Post-treatment

Consenting Process (for study, fMRI, & testing)

X

   

Measures of Sample Characteristics and Eligibility

 MINI International Neuropsychiatric Interview- 7 (MINI-7)

X

   

 Self-Administered Comorbidity Questionnaire (SCQ)

 

X

X

X

 Alcohol Use Disorders Identification Test (AUDIT)

 

X

X

X

 Drug Use Disorders Identification Test (DUDIT)

 

X

X

X

 PTSD Checklist for DSM-5 (PCL-5)

 

X

 

X

 PCL-5 Weekly Questionnaire

  

X

 

 Life Events Checklist for DSM-5 (LEC-5)

 

X

 

X

Estimates of Intellectual Premorbid Functioning

 Advanced Clinical Solutions (ACS; Test of Premorbid Functioning)

 

X

  
  1. Data collection occurs at 4 time points as shown above. Enrollment and Baseline research sessions occur prior to the commencement of TMS treatment session 1. The 1 Week research session occurs after completion of the first TMS treatment sessions within the first week, targeting the first 5 TMS sessions. The Post-treatment research session occurs after completion of TMS treatment, targeting 30 TMS sessions